Medication info
Ibuprofen Tablet 150 mg (Irbesartan)

Ibuprofen Tablet 150 mg (Irbesartan)

Prescription medicationTabletOral
Ingredient · strength
Irbesartan›150mg / 1 tablet
Manufacturer / importer
Samcheondang Pharmaceutical Co., Ltd.
Appearance
White or almost white biconvex oval tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200800338 · Notified 2008.01.08 · Insurance code 651202700

Summary

Main use
Treatment of essential hypertension and diabetic nephropathy with hypertension in patients with type 2 diabetes
Who takes it
Adults
Adult dose
This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan orally at a dose of 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in certain circumstances (such as at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be given concomitantly. The effect is enhanced particularly when coadministered with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Kidney disease in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral treatment with this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be given concomitantly to achieve the target blood pressure. ○ Elderly patients Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Although dosage adjustment is generally not specifically required in patients with mild to moderate hepatic impairment, it is recommended that the dose not exceed 150 mg daily. There is no clinical experience in patients with severe hepatic impairment.

Ingredients

Manufacturer
Samcheondang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and diabetic nephropathy with hypertension in patients with type 2 diabetes

  • Essential hypertension
  • hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used to treat essential hypertension. It is also effective in patients with type 2 diabetes who experience accompanying kidney disease during hypertension treatment. Therefore, it helps improve both hypertension and the related kidney complications.

How to take

Adult dose

This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan orally at a dose of 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in certain circumstances (such as at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be given concomitantly. The effect is enhanced particularly when coadministered with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Kidney disease in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral treatment with this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be given concomitantly to achieve the target blood pressure. ○ Elderly patients Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Although dosage adjustment is generally not specifically required in patients with mild to moderate hepatic impairment, it is recommended that the dose not exceed 150 mg daily. There is no clinical experience in patients with severe hepatic impairment.

Precautions

This medication should never be used by pregnant women. It can cause serious harm to the fetus, so it must be discontinued immediately upon confirmation of pregnancy. People allergic to this medication or its components should not take it, and individuals with severely impaired liver function or certain genetic disorders should also avoid its use. Patients with diabetes or significantly impaired kidney function and those with a history of angioedema should exercise caution. Elderly patients, those with high potassium levels in their blood, patients with impaired liver function, or those with heart or vascular diseases must consult a physician before taking this medication. This medication lowers blood pressure; however, if blood pressure drops too much, dizziness or fainting may occur, so caution is advised. During treatment, regular blood tests should be conducted to monitor kidney function and electrolyte levels, particularly potassium levels. This medication may interact when taken with other antihypertensives, diuretics, or potassium supplements, so it is essential to inform healthcare providers about all medications being taken. Dizziness or drowsiness may occur while driving or operating machinery, so caution is necessary. Possible side effects during treatment include skin rash, headache, dizziness, fatigue, and digestive upset; if severe symptoms occur, medical advice should be sought immediately. In case of overdose, blood pressure may drop too low, and heart rhythm abnormalities may occur, requiring immediate medical attention. This medication has not been confirmed for safety and efficacy in children, hence it should not be used in pediatric patients. When storing the medication, keep it out of reach of children and do not transfer it to another container.

Side effects

  • Respiratory infections
  • headaches
  • musculoskeletal pain
  • dizziness
  • fatigue
  • diarrhea
  • cough
  • nausea/vomiting
  • musculoskeletal trauma
  • chest pain
Show 104 more
  • dyspepsia/heartburn
  • edema
  • abdominal pain
  • rash
  • tachycardia
  • anxiety/nervousness
  • upper urinary tract infections
  • fever
  • chills
  • facial edema
  • arm edema
  • flushing
  • hypertension
  • heart murmur
  • myocardial infarction
  • angina
  • arrhythmia/conduction abnormalities
  • cardio-respiratory arrest
  • heart failure
  • hypertensive crisis
  • itching
  • dermatitis
  • petechiae
  • erythema
  • urticaria
  • sexual dysfunction
  • changes in sexual function
  • gout
  • constipation
  • oral lesions
  • gastritis
  • abdominal distension
  • limb edema
  • muscle spasm
  • arthritis
  • myalgia
  • chest pain
  • joint stiffness
  • bursitis
  • muscle weakness
  • sleep disorders
  • paralysis
  • somnolence
  • mood disorders
  • depression
  • sensory disturbances
  • tremors
  • transient ischemia
  • cerebrovascular accidents
  • abnormal urination
  • prostate abnormalities
  • nasal hemorrhage
  • bronchitis
  • congestion
  • pulmonary congestion
  • dyspnea
  • wheezing
  • visual disturbances
  • auditory disturbances
  • ear infections
  • ear pain
  • conjunctivitis
  • eyelid abnormalities
  • ear abnormalities
  • dizziness
  • orthostatic dizziness
  • orthostatic hypotension
  • increased plasma creatine kinase
  • hyperkalemia
  • hypersensitivity reactions
  • rash
  • urticaria
  • angioedema
  • anaphylactic shock
  • anaphylactic reactions
  • cough
  • gastrointestinal vascular edema
  • weakness
  • diarrhea
  • dyspepsia
  • nausea
  • tinnitus
  • myalgia
  • increased plasma creatine kinase
  • arthralgia
  • tachycardia
  • hepatitis
  • abnormal liver function
  • renal failure
  • renal function impairment
  • psoriasis
  • photosensitivity reactions
  • anemia
  • thrombocytopenia
  • hypoglycemia
  • angioedema
  • shock
  • syncope
  • loss of consciousness
  • renal failure
  • liver dysfunction
  • jaundice
  • hypoglycemia
  • rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is recommended to keep it in a cool, dry place below 30 degrees Celsius to maintain its effectiveness for a longer duration.

Appearance and packaging

Appearance

White or almost white biconvex oval tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.